Malaria is highly endemic throughout Burkina Faso. The northern Sahel region has short seasonal transmission of two to three months and is prone to epidemics, while the central region experiences long seasonal transmission lasting four to six months. Permanent transmission occurs in the southwest with peaks during the rainy season.
The high intensity of malaria transmission posits the disease as the leading cause of illness and mortality in the country, with an estimated 40 000 deaths each year. While malaria is a risk to the entire population, young children and pregnant women are most at risk. In 2011, malaria accounted for 45.4% of visits to health facilities, 52.5% of hospitalizations, and 34.2% of deaths. Among children less than five years of age these figures increase to 54.2%, 80.4% and 87.9%, respectively.
Burkina Faso’s 2011–2015 National Malaria Strategic Plan (NMSP) encompasses prevention, treatment and support strategies that aim to reduce malaria morbidity by 75% compared to 2010, and mortality to almost zero.
The prevention component aims at reducing exposure among the entire population by increasing use of long-lasting insecticidal nets (LLINs) to 100% by the end of 2015. Treatment strategies focus on treating 100% of malaria cases with appropriate antimalarials, and improving case management and reporting by community health workers and health facilities. Support strategies encompass advocacy, behaviour change communication (BCC) and monitoring and evaluation.
The government supports health districts to implement the LLIN component, and Plan International focuses on interventions at the community level in partnership with four national NGOs: Africare; Christian Relief and Development Organisation (CREDO); Union des Religieux et Coutumiers du Burkina contre le SIDA (URCB); and Réseau d’Accès aux Médicaments Essentiels (RAME).
This study finds that community health workers (CHWs) are rarely used in Burkina Faso to treat malaria in children.Read more
The anti-cE5 IgG response is shown here to be a sensitive indicator of human exposure to anopheline vectors and to represent an additional tool for malaria epidemiological studies. It may be especially useful in conditions of low vector density, to monitor transiently exposed individuals (i.e. travellers/workers/soldiers spending a few months in tropical Africa) and to evaluate the impact of insecticide treated nets on vector control.Read more
Clinical trial results provide evidence for introducing this Artemisinin Derivative-based Combination Therapy into Africa's current malaria treatment arsenal to help tackle the number one parasitic killer. The study was conducted in three African countries: Burkina Faso, Kenya, and Tanzania.Read more
Efforts to stop millions children dying needlessly from malaria must continue, children's organisation Plan International has warned.Read more
Malaria No More first visited Saaba, Burkina Faso with MNM Ambassador Katharine McPhee and her husband Nick Cokas, who helped fund a school at the AESSO Community Center in 2007. Today, in partnership with the director at AESSO, Patricia Rouamba, we’re working to ensure every student attending school this year, and every child living at the orphanage will sleep under a life-saving mosquito net at night. The health clinics will…Read more
Nine-year old Akili Raphael found inspiration from another child who was involved in the fight against malaria. After reading a story about a twelve-year old girl who raised funds to purchase bed nets, he was so inspired that he shared the story with his mom and told her that he wanted to do something about malaria too.Read more